Specialty Pharmacy Precertification List Expansion Effective April 1 (Healthy Blue + Medicare HMO D-SNP)

December 12, 2022
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Pharmacy
media-label
label
link
Pharmacy
icon-position
right
full-width
false
full-width-mobile
false

Please note, this communication applies to Healthy Blue + Medicare℠ (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina (Blue Cross NC).

Effective for dates of service on and after April 1, 2023, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

lh-header-fill
true
lh-sticky-header-column
true
HCPCS or CPT® codes Medicare Part B drugs
C9399, J3490, J3590 Spevigo (spesolimab-sbzo)
C9399, J3490, J3590 Xenpozyme (olipudase alfa)

For more information, please visit Healthy Blue + Medicare.

NCBCBS-CR-008578-22-CPN8058 December 2022